-
Product Insights
Recurrent Glioblastoma Multiforme (GBM) – Drugs In Development, 2023
Global Markets Direct’s, ‘Recurrent Glioblastoma Multiforme (GBM) - Drugs In Development, 2023’, provides an overview of the Recurrent Glioblastoma Multiforme (GBM) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Recurrent Glioblastoma Multiforme (GBM), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pegargiminase in Soft Tissue Sarcoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Pegargiminase in Soft Tissue Sarcoma Drug Details: Pegargiminase (ADI-PEG 20) is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pegargiminase in Glioblastoma Multiforme (GBM)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Pegargiminase in Glioblastoma Multiforme (GBM) Drug Details: Pegargiminase (ADI-PEG 20) is under development for the...
-
Product Insights
Vista Hermosa Solar PV Park
Vista Hermosa Solar PV Park is a solar PV project located in Cocle, Panama. The project is owned and developed by Polaris Renewable Energy Inc. The project is currently under construction. Empower your strategies with our Vista Hermosa Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections...
-
Product Insights
San Jacinto Tizate 1 Phase II & III
San Jacinto Tizate 1 Phase II & III is a geothermal project located in Leon, Nicaragua. The project is owned and developed by Polaris Energy Nicaragua SA. The project came online in 2012. Empower your strategies with our San Jacinto Tizate 1 Phase II & III report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LK-101 in Hepatocellular Carcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LK-101 in Hepatocellular Carcinoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LK-101 in Hepatocellular Carcinoma Drug Details: Cell therapy is under investigation for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NBTXR-3 in Cervical Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NBTXR-3 in Cervical Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NBTXR-3 in Cervical Cancer Drug Details: NBTXR-3 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – 4SC-205 in Kidney Cancer (Renal Cell Cancer)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - 4SC-205 in Kidney Cancer (Renal Cell Cancer) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.4SC-205 in Kidney Cancer (Renal Cell Cancer) Drug Details:4SC-205 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pegargiminase in Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pegargiminase in Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pegargiminase in Acute Myelocytic Leukemia (AML, Acute...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Golimumab in Type 1 Diabetes (Juvenile Diabetes)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Golimumab in Type 1 Diabetes (Juvenile Diabetes) Drug Details:Golimumab (Simponi) is a human monoclonal antibody, acts...